We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Technology Quickly Diagnoses Malaria

By LabMedica International staff writers
Posted on 06 Oct 2016
The gold standard for malaria diagnosis is manual microscopic evaluation of Giemsa stained blood smears; however, the utility of this approach is limited by the skill of an expert microscopist. More...
Further, both the staining process and microscopic examination can be time consuming.

A computerized method has been developed that relies on computers and light-based holographic scans correctly identified malaria-infected cells in a blood sample and this technique does not require any human intervention and could form the basis for a rapid field test for malaria.

A multidisciplinary team of scientists from Duke University (Durham, NC, USA) collected whole blood samples from healthy donors and red blood cells (RBCs) were isolated and purified. RBCs were infected with a Plasmodium falciparum, and synchronized. During the 48-hour life cycle, infected RBCs were isolated from the general RBC population by magnetic sorting via a magnetic cell separation system (MACS, Miltenyi Biotec, Bergisch Gladbach, Germany) to separate uninfected RBCs from those containing parasites. The team used quantitative phase spectroscopy system (QPS) to image red blood cells. Refocused images are analyzed to extract 23 morphological descriptors based on the phase information.

Machine learning algorithms were used to distinguish uninfected RBCs from three different hemozoin containing stages of P. falciparum infected RBCs (early trophozoite–ET, late trophozoite–LT, and schizont–S). All of the classification methods have higher specificities compared to their sensitivities when distinguishing uninfected from infected RBCs for all three stages of infection. The specificities ranged from 98.4% for LT with the early stage of infection (ET) to 100% for the best performing method (LDC) for both LT and S stages.

The authors concluded that one of the main strengths of using machine learning algorithms to analyze the extracted parameters is that the identification of RBC infection will be based on quantified metrics and pre-built classifiers that requires minimal operator training. In order to enable automated imaging in the future, a microfluidic device with controlled flow rates can be combined with the analysis approach that would allow high throughput.

Adam Wax, PhD, a professor of biomedical engineering who helped pioneer the technology, said, “With this technique, the path is there to be able to process thousands of cells per minute. That’s a huge improvement to the 40 minutes it currently takes a field technician to stain, prepare and read a slide to personally look for infection,” The study was published on September 16, 2016, in the journal Public Library of Science ONE.

Related Links:
Duke University
Miltenyi Biotec

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: The MyChoice CDx test, currently used as a companion diagnostic in ovarian cancer, will generate the PrGIS score and is being advanced for use in prostate cancer. (Photo courtesy of Myriad Genetics)

Collaboration Advances Genomic Instability Biomarker for Prostate Cancer

In prostate cancer, homologous recombination deficiency is emerging as an important prognostic and predictive biomarker. Measuring the chromosomal instability associated with this pathway may help guide... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.